Primary aldosteronism, Treatment-resistant hypertension, Uncontrolled hypertension
Conditions
Interventions
None listed
Sponsors
Astrazeneca AB
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Countries
Germany
Outcome results
None listed